300003 樂普醫療
按盤價 
13.170 +1.930 (+17.171%)
13.170 +1.930 (+17.171%) | 2024/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 3,383,887 | -21.33% | 7,979,899 | 10,609,442 | 10,659,735 | 8,038,668 | |
| 減：營業總成本 | 2,586,485 | -19.53% | 6,354,887 | 7,926,747 | 8,207,653 | 6,192,510 | |
| 其中:營業成本 | 1,207,882 | -20.01% | 2,853,286 | 3,983,286 | 4,156,637 | 2,653,774 | |
| 財務費用 | 14,253 | -60.17% | 84,929 | 92,578 | 171,760 | 266,665 | |
| 資產減值損失 | (18,401) | 849.08% | (165,092) | (37,953) | (9,448) | (20,978) | |
| 公允價值變動收益 | 7,179 | -55.88% | 3,092 | 4,420 | 29,340 | 451,858 | |
| 投資收益 | (19,591) | -14.96% | (16,533) | (75,335) | (396,883) | (153,799) | |
| 其中：對聯營企業和合營企業的投資收益 | (34,139) | 114.73% | (24,361) | (90,833) | (152,254) | (142,769) | |
| 營業利潤 | 801,968 | -27.99% | 1,547,215 | 2,623,139 | 2,144,602 | 2,149,178 | |
| 利潤總額 | 796,027 | -30.53% | 1,554,498 | 2,611,782 | 2,146,152 | 2,203,313 | |
| 減：所得稅費用 | 106,019 | -28.29% | 262,147 | 365,726 | 365,733 | 326,235 | |
| 淨利潤 | 690,008 | -30.86% | 1,292,351 | 2,246,055 | 1,780,419 | 1,877,079 | |
| 減：非控股權益 | (7,234) | -119.81% | 34,151 | 42,276 | 61,094 | 75,146 | |
| 股東淨利潤 | 697,242 | -27.48% | 1,258,200 | 2,203,779 | 1,719,325 | 1,801,933 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.377 | -27.06% | 0.676 | 1.223 | 0.960 | 1.014 | |
| 每股派息 (元) * | 0.142 | -- | 0.331 | 0.341 | 0.275 | 0.228 | |
| 每股淨資產 (元) * | 8.336 | 1.09% | 8.381 | 7.940 | 6.239 | 5.471 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
